Clinical Trial Update: The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy [NA]

View source ↗

Summary

A clinical trial evaluating sodium bicarbonate to prevent contrast-induced nephropathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Lenox Hill Hospital | Conditions: Contrast Induced Nephropathy | NA | Status: TERMINATED